Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | C41 - Update in Movement Disorders 3: Update on Clinical Trials in Parkinson’s and Huntington’s Diseases

Monday 04/19/21
08:00 AM - 09:00 AM EDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Tanya Simuni, MD, FAAN
Jacinda B. Sampson, MD, PhD
Movement Disorders
Participants should become familiar with the recently completed and on-going PD clinical trials. Participants should become familiar with the criteria to identify patients most appropriate for PD disease modifying interventions. Participants should become familiar with the with the recently completed and on-going HD clinical trials
1.00 CME credit
Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Introductory
Advanced Practice Provider
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
08:00 AM - 08:30 AM EDT Speaker Overview of PD Experimental Therapeutics: Focus on Disease Modification Trials
Tanya Simuni, MD, FAAN
08:30 AM - 08:50 AM EDT Speaker Update on Clinical Trials in Huntington's Disease
Tiago Mestre, MD, MSC
08:50 AM - 09:00 AM EDT Q&A Live Q&A
Tanya Simuni, MD, FAAN, Tiago Mestre, MD, MSC
Faculty Disclosures
Tanya Simuni, MD, FAAN Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Tiago Mestre, MD, MSC Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CHDI. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SUNOVION. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Valeo Pharma. Dr. Mestre has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Valeo Pharma. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mestre has received research support from CIHR. The institution of Dr. Mestre has received research support from Ontario Research Fund. The institution of Dr. Mestre has received research support from MJFF. The institution of Dr. Mestre has received research support from Parkinson Canada. The institution of Dr. Mestre has received research support from University of Ottawa/PRC.
Jacinda B. Sampson, MD, PhD Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.